Browsing by Author Hutchison, Brian

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2006A one-year, randomised, open label, parallel group study to investigate the safety and efficacy of enteric-coated Mycophenolate sodium (EC-MPS) in combination with full dose or reduced dose cyclosporine microemulsion (CSA-ME), basiliximab and steroids in de novo kidney transplantationChadban, Steven; Chapman, Jeremy; Ierino, Francesco; Walker, Raellen; Campbell, Sandra J; Hutchison, Brian; Irish, A.; Pussell, Bruce A.; Russ, Graeme; Thompson, N.; Trevillian, P; Central Clinical School: Medicine; Western Clinical School: Westmead Millennium Institute; Medicine Faculty Office; School of Public Health: NH&MRC Clinical Trials CentreA one-year, randomised, open label, parallel group study to investigate the safety and efficacy of enteric-coated Mycophenolate sodium (EC-MPS) in combination with full dose or reduced dose cyclosporine microemulsion (CSA-ME), basiliximab and steroids in de novo kidney transplantation, Immunology and Cell Biology, vol.84,(3),2006,pp A6-A6
2006Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation.Eris, Josette; Campistol, Josep M.; Claesson, Kerstin; et, al; Friend, Peter; Hutchison, Brian; Morales, Jose M.; Oberbauer, Rainer; Rostaing, Lionel; Russ, Graeme; Stallone, Giovanni; Concord Clinical School: MedicineSirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation., Journal of the American Society of Nephrology, vol.17,(2),2006,pp 581-589
2006Sirolimus therapy after early cyclosporine withdrawal reduces the risk of malignancy at 5 years after renal transplantationChapman, Jeremy; Eris, Josette; Walker, Raellen; Brault, Yves; Burke, James; Campbell, Scott; Hutchison, Brian; Mahoney, John; Neylan, John F.; Pussell, Bruce A.; Russ, Graeme; Scarola, Joseph; Western Clinical School: Westmead Millennium Institute; Concord Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreSirolimus therapy after early cyclosporine withdrawal reduces the risk of malignancy at 5 years after renal transplantation, Immunology and Cell Biology, vol.84,(3),2006,pp A19-A19